Association of normal body mass index and weight loss with long-term major cardiovascular events after PCI for myocardial infarction

References

• Ellis SG, Elliot J, Horrigan M, et al. Low-normal or excessive body mass index: newly identified and powerful risk factors for death and other complications with percutaneous coronary intervention. Am J Cardiol. 1996;78(6):642–646. doi: 10.1016/s0002-9149(96)00386-4.
   PubMed Web of Science ®Google Scholar
• Holroyd EW, Sirker A, Kwok CS, et al. The relationship of body mass index to percutaneous coronary intervention outcomes: does the obesity paradox exist in contemporary percutaneous coronary intervention cohorts? Insights from the British cardiovascular intervention society registry. JACC Cardiovasc Interv. 2017;10(13):1283–1292. doi: 10.1016/j.jcin.2017.03.013.
   PubMed Web of Science ®Google Scholar
• Wang ZJ, Zhou YJ, Galper BZ, et al. Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease; a systematic review and meta-analysis. Heart. 2015;101(20):1631–1638. doi: 10.1136/heartjrnl-2014-307119.
   PubMed Web of Science ®Google Scholar
• Wolny R, Maehara A, Liu Y, et al. The obesity paradox revisited: body mass index and long-term outcomes after PCI from a large pooled patient-level database. EuroIntervention. 2020;15(13):1199–1208. doi: 10.4244/EIJ-D-19-00467.
   PubMed Web of Science ®Google Scholar
• Alhuneafat L, Jabri A, Abu Omar Y, et al. Relationship between body mass index and outcomes in acute myocardial infarction. J Clin Med Res. 2022;14(11):458–465. doi: 10.14740/jocmr4818.
   PubMedGoogle Scholar
• Pack QR, Rodriguez-Escudero JP, Thomas RJ, et al. The prognostic importance of weight loss in coronary artery disease: a systematic review and meta-analysis. Mayo Clin Proc. 2014;89(10):1368–1377. doi: 10.1016/j.mayocp.2014.04.033.
   PubMed Web of Science ®Google Scholar
• Otterstad JE, Norum IB, Ruddox V, et al. Prognostic impact of non-improvement of global longitudinal strain in patients with revascularized acute myocardial infarction. Int J Cardiovasc Imaging. 2021;37(12):3477–3487. doi: 10.1007/s10554-021-02349-2.
   PubMed Web of Science ®Google Scholar
• Peersen K, Munkhaugen J, Gullestad L, et al. The role of cardiac rehabilitation in secondary prevention after coronary events. Eur J Prev Cardiol. 2017;24(13):1360–1368. doi: 10.1177/2047487317719355.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J. 2012;33(20):2551–2567. doi: 10.1093/eurheartj/ehs184.
   PubMed Web of Science ®Google Scholar
• Windecker S, Koth P, Alonso F, et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014;35(37):2541–2619.
   PubMed Web of Science ®Google Scholar
• Liu S-H, Lin Y-Z, Han S, et al. The obesity paradox in ST-segment elevation myocardial infarction patients: a meta-analysis. Ann Noninvasive Electrocardiol. 2023;28(2):e13022. doi: 10.1111/anec.13022.
   PubMed Web of Science ®Google Scholar
• Al-Shaar L, Li Y, Rimm EB, et al. Body mass index and mortality among adults with incident myocardial infarction. Am J Epidemiol. 2021;190(10):2019–2028. https://academic.oup.com/aje/article/190/10/2019/6255430 doi: 10.1093/aje/kwab126.
   PubMed Web of Science ®Google Scholar
• Akin I, Tölg R, Hochadel M, et al. No evidence of “obesity paradox” after treatment with drug-eluting stents in a routine clinical practice: results from the prospective multicenter German DES.DE (German Drug-Eluting Stent) Registry. JACC Cardiovasc Interv. 2012;5(2):162–169. doi: 10.1016/j.jcin.2011.09.021.
   PubMed Web of Science ®Google Scholar
• Diletti R, Garcia-Garcia HM, Bourantas C, et al. Impact of body mass index on long-term clinical outcomes after second-generation drug-eluting stent implantation: insights from the international global RESOLUTE program. Catheter Cardiovasc Interv. 2015;85(6):952–958. doi: 10.1002/ccd.25828.
   PubMed Web of Science ®Google Scholar
• Berglund L, Risérus U, Hambraeus K. Repeated measures of body mass index and waist circumference in the assessment of mortality risk in patients with myocardial infarction. Ups J Med Sci. 2019;124(1):78–82. doi: 10.1080/03009734.2018.1494644.
   PubMed Web of Science ®Google Scholar
• Yui H, Ebisawa S, Miura T, et al. Impact of changes in body mass index after percutaneous coronary intervention on long-term outcomes in patients with coronary artery disease. Heart Vessels. 2020;35(12):1657–1663. doi: 10.1007/s00380-020-01648-3.
   PubMed Web of Science ®Google Scholar
• Yamashita Y, Shiomi H, Morimoto H, et al. Cardiac and non-cardiac causes of long-term mortality in ST-segment-elevation acute myocardial infarction patients who underwent primary percutaneous coronary intervention. Circ Cardiovas Qual Outcomes. 2017;10(1):e002790.
   PubMed Web of Science ®Google Scholar
• Brener SJ, Tarantini G, Leon MB, et al. Cardiovascular and noncardiovascular death after percutaneous coronary intervention: insights from 32 882 patients enrolled in 21 randomized trials. Circ Cardiovasc Interv. 2018;11(7):e006488. doi: 10.1661/CIRCINTERVENTIONS.118.0064881.
   PubMed Web of Science ®Google Scholar
• Rimm EB, Stampfer MJ, Colditz GA, et al. Validity of self-reported waist and hip circumferences in men and women. Epidemiology. 1990;1(6):466–473. doi: 10.1097/00001648-199011000-00009.
   PubMedGoogle Scholar